Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Novartis
Teva
Deloitte
Colorcon
AstraZeneca
Merck
Fuji
Healthtrust
UBS

Generated: January 17, 2018

DrugPatentWatch Database Preview

ORNIDYL Drug Profile

« Back to Dashboard

When do Ornidyl patents expire, and what generic alternatives are available?

Ornidyl is a drug marketed by Sanofi Aventis Us and is included in one NDA.

The generic ingredient in ORNIDYL is eflornithine hydrochloride. There are two drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the eflornithine hydrochloride profile page.

US Patents and Regulatory Information for ORNIDYL

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for ORNIDYL

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Subscribe ➤ Subscribe
Sanofi Aventis Us ORNIDYL eflornithine hydrochloride INJECTABLE;INJECTION 019879-002 Nov 28, 1990 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Baxter
Moodys
McKesson
Federal Trade Commission
Queensland Health
AstraZeneca
Cipla
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot